Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website http://www.journalmc.org

Case Report

Volume 4, Number 6, June 2013, pages 411-415


Anemia of Inflammation (AI) Elevated Serum Hepcidin Level and Therapeutic Intravenous Administration of Iron

Figure

Figure 1.
Figure 1. Clinical course.

Table

Table 1. Laboratory Data at and Around Admission
 
( ) normal values.
RBC: 3.07 × 1012/LTotal Protein: 6.3 g/dLANF: < 40
Hb: 8.5 g/dLAlb: 2.7 g/dLanti-DNA Ab: < 80
Ht: 27.9%Glb: 3.6 g/dLCH50: 56.4/mL
Ret: 1.8%Total Bilirubin: 0.6 mg/dLRF: (+)
MCV: 91 flAST: 12 IU/Lanti-CCP Ab: < 0.4 U/mL
MCH: 28 pgALT: 6 IU/L
MCHC: 31%ALP: 277 IU/LCoombs direct: (-)
Plt: 312 × 109/Lγ-GTP: 125 IU/Lindirect : (-)
WBC: 6.2 × 109/LLDH: 113 IU/L
Uric Acid: 3.4 mg/dLfT3: 1.7 pg/mL
Fe: 16 µg/dLCreatinine: 0.7 mg/dLfT4: 1.5 ng/dL
TIBC: 201 µg/dLBUN :7.7 mg/dLTSH: 2.0 µIU/mL
UIBC: 177 µg/dLTotal Cholesterol: 144 mg/dL
Ferritin: 496 ng/mLTriglyceride: 101 mg/dLCA-125: 8.8 U/mL (< 35.0)
Blood Sugar: 113 mg/dL
Vitamin: B12 358 pg/mL
Folic Acid: 7.6 ng/mLAlb: 48.2%IgG: 1,499 mg/dL
α1-gl: 5.0%IgA: 190 mg/dL
CRP: 8.7 mg/dLα2-gl: 13.0%IgM: 111 mg/dL
sIL-2R: 619 U/mL (124 - 466)β-gl: 11.4%
IL-6: 26.4 pg/mL (< 4.0)γ-g: 22.4%
EPO: 32.7 mU/mL (9.1 - 32.8)M-protein: (-)
Hepcidin-25: 80.8 ng/mL (7.8 ± 7.0)